150 related articles for article (PubMed ID: 3342399)
1. Transfer by pro gene transfection of tumor promoter-sensitive phenotype to promotion-insensitive JB6 cells.
Colburn NH; Smith BM; Wendel EJ; Dowjat WK; Shimada T
Cancer Res; 1988 Mar; 48(5):1195-200. PubMed ID: 3342399
[TBL] [Abstract][Full Text] [Related]
2. Comparison of mouse pro-1 and pro-2 transfectants for responses to tumor promoters and antipromoters.
Colburn NH; Smith BM; Wendel EJ; Nakamura Y; Winterstein D
Cancer Res; 1988 Nov; 48(21):6076-80. PubMed ID: 3139288
[TBL] [Abstract][Full Text] [Related]
3. Genes that cooperate with tumor promoters in transformation.
Colburn NH; Smith BM
J Cell Biochem; 1987 Jun; 34(2):129-42. PubMed ID: 3597557
[TBL] [Abstract][Full Text] [Related]
4. Inhibition by tumor-promoting phorbol esters of procollagen synthesis in promotable JB6 mouse epidermal cells.
Dion LD; Bear J; Bateman J; De Luca LM; Colburn NH
J Natl Cancer Inst; 1982 Nov; 69(5):1147-54. PubMed ID: 6957659
[TBL] [Abstract][Full Text] [Related]
5. Osteopontin induction is required for tumor promoter-induced transformation of preneoplastic mouse cells.
Chang PL; Cao M; Hicks P
Carcinogenesis; 2003 Nov; 24(11):1749-58. PubMed ID: 12919959
[TBL] [Abstract][Full Text] [Related]
6. Expression of antisense osteopontin RNA inhibits tumor promoter-induced neoplastic transformation of mouse JB6 epidermal cells.
Su L; Mukherjee AB; Mukherjee BB
Oncogene; 1995 Jun; 10(11):2163-9. PubMed ID: 7784060
[TBL] [Abstract][Full Text] [Related]
7. Four-day duration of tumor promoter exposure required to transform JB6 promotion-sensitive cells to anchorage independence.
Dion LD; Gindhart TD; Colburn NH
Cancer Res; 1988 Dec; 48(24 Pt 1):7126-31. PubMed ID: 3191489
[TBL] [Abstract][Full Text] [Related]
8. Membrane and genetic events in tumor promotion: studies with promoter resistant variants of JB6 cells.
Colburn NH; Lerman MI; Srinivas L; Nakamura Y; Gindhart TD
Princess Takamatsu Symp; 1983; 14():155-66. PubMed ID: 6394588
[TBL] [Abstract][Full Text] [Related]
9. Tumor promoter-induced ornithine decarboxylase gene expression occurs independently of AP-1 activation.
Jansen AP; Colburn NH; Verma AK
Oncogene; 1999 Oct; 18(42):5806-13. PubMed ID: 10523861
[TBL] [Abstract][Full Text] [Related]
10. Transfer of sensitivity to tumor promoters by transfection of DNA from sensitive into insensitive mouse JB6 epidermal cells.
Colburn NH; Talmadge CB; Gindhart TD
Mol Cell Biol; 1983 Jul; 3(7):1182-6. PubMed ID: 6888378
[TBL] [Abstract][Full Text] [Related]
11. Tumor promoter induces high mobility group HMG-Y protein expression in transformation-sensitive but not -resistant cells.
Cmarik JL; Li Y; Ogram SA; Min H; Reeves R; Colburn NH
Oncogene; 1998 Jul; 16(26):3387-96. PubMed ID: 9692546
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of tumor promoter-induced transformation by retinoids that transrepress AP-1 without transactivating retinoic acid response element.
Li JJ; Dong Z; Dawson MI; Colburn NH
Cancer Res; 1996 Feb; 56(3):483-9. PubMed ID: 8564958
[TBL] [Abstract][Full Text] [Related]
13. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.
Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH
Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737
[TBL] [Abstract][Full Text] [Related]
14. Responses of preneoplastic epidermal cells to tumor promoters and growth factors: use of promoter-resistant variants for mechanism studies.
Colburn NH; Wendel E; Srinivas L
J Cell Biochem; 1982; 18(3):261-70. PubMed ID: 7068782
[TBL] [Abstract][Full Text] [Related]
15. Extracellular calcium requirement for promotion of transformation in JB6 cells.
Smith BM; Gindhart TD; Colburn NH
Cancer Res; 1986 Feb; 46(2):701-6. PubMed ID: 3079668
[TBL] [Abstract][Full Text] [Related]
16. Transforming JB6 cells exhibit enhanced integrin-mediated adhesion to osteopontin.
Chang PL; Chambers AF
J Cell Biochem; 2000 Apr; 78(1):8-23. PubMed ID: 10797562
[TBL] [Abstract][Full Text] [Related]
17. Role of cytoskeleton changes and expression of the H-ras oncogene during promotion of neoplastic transformation in mouse epidermal JB6 cells.
Takahashi K; Heine UI; Junker JL; Colburn NH; Rice JM
Cancer Res; 1986 Nov; 46(11):5923-32. PubMed ID: 3093072
[TBL] [Abstract][Full Text] [Related]
18. Cellular dichotomy between anchorage-independent growth responses to bFGF and TPA reflects molecular switch in commitment to carcinogenesis.
Waters KM; Tan R; Opresko LK; Quesenberry RD; Bandyopadhyay S; Chrisler WB; Weber TJ
Mol Carcinog; 2009 Nov; 48(11):1059-69. PubMed ID: 19526458
[TBL] [Abstract][Full Text] [Related]
19. Induction of transformation progression in type 5 adenovirus-transformed rat embryo cells by a cloned protein kinase C beta 1 gene and reversal of progression by 5-azacytidine.
Su ZZ; Shen R; O'Brian CA; Fisher PB
Oncogene; 1994 Apr; 9(4):1123-32. PubMed ID: 7510863
[TBL] [Abstract][Full Text] [Related]
20. Lack of suppression of tumor cell phenotype by overexpression of TIMP-3 in mouse JB6 tumor cells identification of a transfectant with increased tumorigenicity and invasiveness.
Sun Y; Kim H; Parker M; Stetler-Stevenson WG; Colburn NH
Anticancer Res; 1996; 16(1):1-7. PubMed ID: 8615593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
